Literature DB >> 18702462

Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.

Jin Qian1, Dominic Cuerrier, Peter L Davies, Zhaozhao Li, James C Powers, Robert L Campbell.   

Abstract

Calpains are intracellular cysteine proteases that catalyze the cleavage of target proteins in response to Ca(2+) signaling. When Ca(2+) homeostasis is disrupted, calpain overactivation causes unregulated proteolysis, which can contribute to diseases such as postischemic injury and cataract formation. Potent calpain inhibitors exist, but of these many cross-react with other cysteine proteases and will need modification to specifically target calpain. Here, we present crystal structures of rat calpain 1 protease core (muI-II) bound to two alpha-ketoamide-based calpain inhibitors containing adenyl and piperazyl primed-side extensions. An unexpected aromatic-stacking interaction is observed between the primed-side adenine moiety and the Trp298 side chain. This interaction increased the potency of the inhibitor toward muI-II and heterodimeric m-calpain. Moreover, stacking orients the adenine such that it can be used as a scaffold for designing novel primed-side address regions, which could be incorporated into future inhibitors to enhance their calpain specificity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18702462      PMCID: PMC2631982          DOI: 10.1021/jm800045t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  34 in total

1.  P2-achiral, P'-extended alpha-ketoamide inhibitors of calpain I.

Authors:  S Chatterjee; D Dunn; M Tao; G Wells; Z Q Gu; R Bihovsky; M A Ator; R Siman; J P Mallamo
Journal:  Bioorg Med Chem Lett       Date:  1999-08-16       Impact factor: 2.823

2.  Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation.

Authors:  C M Hosfield; J S Elce; P L Davies; Z Jia
Journal:  EMBO J       Date:  1999-12-15       Impact factor: 11.598

3.  A Ca(2+) switch aligns the active site of calpain.

Authors:  Tudor Moldoveanu; Christopher M Hosfield; Daniel Lim; John S Elce; Zongchao Jia; Peter L Davies
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

4.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

Review 5.  Base-excision repair of oxidative DNA damage.

Authors:  Sheila S David; Valerie L O'Shea; Sucharita Kundu
Journal:  Nature       Date:  2007-06-21       Impact factor: 49.962

6.  Molecular mode of action of a covalently inhibiting peptidomimetic on the human calpain protease core.

Authors:  Qingshan Li; Robert P Hanzlik; Robert F Weaver; Ernst Schönbrunn
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

7.  Structural basis for recognition of the tra mRNA precursor by the Sex-lethal protein.

Authors:  N Handa; O Nureki; K Kurimoto; I Kim; H Sakamoto; Y Shimura; Y Muto; S Yokoyama
Journal:  Nature       Date:  1999-04-15       Impact factor: 49.962

8.  Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.

Authors:  U M Ohndorf; M A Rould; Q He; C O Pabo; S J Lippard
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

9.  Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.

Authors:  Z Li; G S Patil; Z E Golubski; H Hori; K Tehrani; J E Foreman; D D Eveleth; R T Bartus; J C Powers
Journal:  J Med Chem       Date:  1993-10-29       Impact factor: 7.446

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  12 in total

Review 1.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

2.  Development of α-helical calpain probes by mimicking a natural protein-protein interaction.

Authors:  Hyunil Jo; Nataline Meinhardt; Yibing Wu; Swapnil Kulkarni; Xiaozhen Hu; Kristin E Low; Peter L Davies; William F DeGrado; Doron C Greenbaum
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

3.  Can Relative Binding Free Energy Predict Selectivity of Reversible Covalent Inhibitors?

Authors:  Payal Chatterjee; Wesley M Botello-Smith; Han Zhang; Li Qian; Abdelaziz Alsamarah; David Kent; Jerome J Lacroix; Michel Baudry; Yun Luo
Journal:  J Am Chem Soc       Date:  2017-11-29       Impact factor: 15.419

4.  Calpain inhibition modulates glycogen synthase kinase 3β pathways in ischemic myocardium: A proteomic and mechanistic analysis.

Authors:  Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Richard T Clements; M Ruhul Abid; Neel R Sodha; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2016-11-16       Impact factor: 5.209

Review 5.  Calpain-2 as a therapeutic target for acute neuronal injury.

Authors:  Yubin Wang; Xiaoning Bi; Michel Baudry
Journal:  Expert Opin Ther Targets       Date:  2017-11-28       Impact factor: 6.902

6.  Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.

Authors:  Asli Ovat; Zhao Zhao Li; Christina Y Hampton; Seneshaw A Asress; Facundo M Fernández; Jonathan D Glass; James C Powers
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

7.  Synthesis of N-trifluoromethyl amides from carboxylic acids.

Authors:  Jianbo Liu; Matthew F L Parker; Sinan Wang; Robert R Flavell; F Dean Toste; David M Wilson
Journal:  Chem       Date:  2021-08-03       Impact factor: 25.832

8.  Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide.

Authors:  Christian-Scott E McCartney; Qilu Ye; Robert L Campbell; Peter L Davies
Journal:  J Biol Chem       Date:  2018-09-25       Impact factor: 5.157

9.  Mechanism of action of thalassospiramides, a new class of calpain inhibitors.

Authors:  Liang Lu; Michael J Meehan; Shuo Gu; Zhilong Chen; Weipeng Zhang; Gen Zhang; Lingli Liu; Xuhui Huang; Pieter C Dorrestein; Ying Xu; Bradley S Moore; Pei-Yuan Qian
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

10.  A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay.

Authors:  Gabriel Velez; Alexander G Bassuk; Kellie A Schaefer; Brian Brooks; Lokesh Gakhar; MaryAnn Mahajan; Philip Kahn; Stephen H Tsang; Polly J Ferguson; Vinit B Mahajan
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.